Cellect Succeeds In First Stem Cell Transplant (APOP) – Investopedia
Benzinga |
Cellect Succeeds In First Stem Cell Transplant (APOP)
Investopedia said it succeeded in conducting the first stem cell transplant procedure using its ApoGraft technology in a Phase 1/2 clinical trial in a blood cancer patient. (See also, Top 10 Most Expensive Medical Procedures.) … Cellect (APOP) Reports First Successful Stem Cell Transplant Procedure Using its ApoGraft Technology Cellect Biotech Up 65% After Stem Cell Transplant Completed In Phase I/II Trial Cellect Biotechnology (APOP) Has Spiked To A New High After Stem Cell Transplant |
